Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1976;4(Suppl 1):S40–S48. doi: 10.1007/BF01638422

The incidence and aetiology of respiratory tract infections in general practice — with emphasis onMycoplasma pneumoniae

Häufigkeit und Ätiologie von Atemwegsinfektionen in der Allgemeinpraxis unter besonderer Berücksichtigung vonMycoplasma pneumoniae

P -A Mårdh 1, B Hovelius, E Nordenfelt, R Rosenberg, L V Soltesz
PMCID: PMC7103261  PMID: 783048

Summary

The incidence of respiratory tract infections in patients seeking medical advice at a community care centre (Dalby) during 1973 and 1974 was studied. About every third patient seen at this primary health station presented with signs of such infections. In the age groups <10, 10–19, 20–39, 40–59 and ≥60 years, respiratory tract infections accounted for 65, 45, 32, 18 and 9% of the total number of diagnoses made during 1974. The aetiology of acute respiratory tract infections in a series of patients seen at this health station was studied. The series included randomly selected cases, but excluded children under seven years of age and patients presenting with signs of acute otitis media and tonsillitis. Attempts to establish the aetiology were made on the basis of the history, the clinical examination, and cultures for beta-haemolytic streptococci andMycoplasma pneumoniae, complement fixation tests for influenza A and B, para-influenza 1, 2, and 3, adeno, cytomegalovirus and respiratory syncytial virus, andChlamydia psittaci. Paul-Bunnell test and tests for cold agglutinins were also performed. With this test battery, an aetiological diagnosis was obtained in only 33% of the 101 patients studied. The findings suggest an infection withM. pneumoniae in 16%, with beta-haemolytic streptococci in 9%, and with viruses (adeno and para-influenza) in 7% of the patients. The present communication highlights the role ofM. pneumoniae in upper respiratory infections, as few data have appeared on such infections in patients seen in general practice. The difficulty of establishing the aetiology of respiratory tract infections and the consequent treatment dilemma is discussed.

Keywords: Influenza, Respiratory Syncytial Virus, Acute Otitis Medium, Tonsillitis, Complement Fixation Test

Literature

  • 1.Axelsson A., Ekedahl C., Hallen O. Acute pharyngeal infection, aetiological and diagnostic viewpoints. Läkartidningen. 1974;71:3923–3926. [PubMed] [Google Scholar]
  • 2.Biberfeld G. Antibodies to brain and other tissues in cases ofMycoplasma pneumoniae infection. Clin. exp. Immunol. 1971;8:319–333. [PMC free article] [PubMed] [Google Scholar]
  • 3.Biberfeld G., Stenbeck J., Johnsson T. Mycoplasma pneumoniae infection in hospitalized patients with acute respiratory illness. Acta path. microbiol. scand. 1968;74:287–300. doi: 10.1111/j.1699-0463.1968.tb03480.x. [DOI] [PubMed] [Google Scholar]
  • 4.Breese B. B., Disney F. H., Rochester N. Y. The accuracy of diagnosis of beta streptococcal infections on clinical grounds. J. Pediatrics. 1954;44:670–673. doi: 10.1016/s0022-3476(54)80008-4. [DOI] [PubMed] [Google Scholar]
  • 5.Cars O., Forsum U. Aspects of the diagnosis of throat infections with beta haemolytic streptococci group A. Läkartidningen. 1975;72:3219–3220. [PubMed] [Google Scholar]
  • 6.Chanock R. M., Mufson M. A., Bloom H. H., James W. D., Fox H. H., Kingston J. R. Eaton agent pneumonia. J. Amer. med. Ass. 1961;175:213–220. doi: 10.1001/jama.1961.03040030037007. [DOI] [PubMed] [Google Scholar]
  • 7.Chanock R. M., Fox H. H., James W. D., Gutekunst R. R., White R. J., Senterfit L. B. Epidemiology ofMycoplasma pneumoniae infection in military recruits. Ann. N. Y. Acad. Sci. 1967;143:484–496. doi: 10.1111/j.1749-6632.1967.tb27692.x. [DOI] [PubMed] [Google Scholar]
  • 8.Christensen P., Kahlmeter G., Jonsson S., Kronvall G. New method for the serological grouping of streptococci with specific antibodies adsorbed to protein A-containing staphylococci. Infect. Immunol. 1973;7:881–885. doi: 10.1128/iai.7.6.881-885.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Davidsohn I., Lee C. L. Serologic diagnosis of infectious mononucleosis. Amer. J. clin. Path. 1964;41:115–125. doi: 10.1093/ajcp/41.2.115. [DOI] [PubMed] [Google Scholar]
  • 10.Evans A. S., Allen V., Sueltmann S. Mycoplasma pneumoniae infections in University of Wisconsin students. Amer. Rev. resp. Dis. 1967;96:237–244. doi: 10.1164/arrd.1967.96.2.237. [DOI] [PubMed] [Google Scholar]
  • 11.Foy H. M., Grayston J. T. Pneumonia,Mycoplasma pneumoniae. In: Top F. H., Wehrle P. F., editors. Communicable and infectious diseases. St. Louis: C. V. Mosby Company; 1972. p. 480. [Google Scholar]
  • 12.Foy H. M., Grayston J. T., Kenny G. E., Alexander E. R., McMahan R. Epidemiology ofMycoplasma pneumoniae infection in families. J. Amer. med. Ass. 1966;197:859–866. [PubMed] [Google Scholar]
  • 13.Foy H. M., Kenny G. E., McMahan R., Mansy A. M., Grayston J. T. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. J. Amer. med. Ass. 1970;214:1666–1672. [PubMed] [Google Scholar]
  • 14.Glezen P. W., Clyde W. A., Jr., Senior R. J., Sheaffer C. I., Denny F. W. Group A streptococci, mycoplasmas and viruses associated with acute pharyngitis. J. Amer. med. Ass. 1967;202:455–460. [PubMed] [Google Scholar]
  • 15.Grayston J. T., Alexander E. R., Kenny G. E., Clarke E. R., Fremont J. C., MacColl W. A. Mycoplasma pneumoniae infections. J. Amer. med. Ass. 1965;191:97–102. doi: 10.1001/jama.1965.03080050015004. [DOI] [PubMed] [Google Scholar]
  • 16.Hers J. F. Ph., Masurel N. Infection withMycoplasma pneumoniae in civilians in the Netherlands. Ann. N. Y. Acad. Sci. 1967;143:447–460. doi: 10.1111/j.1749-6632.1967.tb27689.x. [DOI] [PubMed] [Google Scholar]
  • 17.Hobson D. Acute respiratory virus infections. Brit. Med. J. 1972;2:229–231. doi: 10.1136/bmj.2.5860.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Holm S. E., Ekedahl C., Bengtson U. Prevention of acute glomerulonephritis with early treatment of tonsillitis with penicillin. Scand. J. infect. Dis. 1973;5:115–122. doi: 10.3109/inf.1973.5.issue-2.06. [DOI] [PubMed] [Google Scholar]
  • 19.Kenny G. E., Grayston J. T. Eaton pleuropneumonia-like organism(Mycoplasma pneumoniae) complement-fixing antigen: Extraction with organic solvents. J. Immunol. 1965;95:19–25. [PubMed] [Google Scholar]
  • 20.von Krech U., Paccaud M. Vergleichende Untersuchungen über die Häufigkeit vonMycoplasma-pneumoniae-Infektion. Genf und St. Gallen. Path. et Microbiol. 1967;30:1037–1040. [PubMed] [Google Scholar]
  • 21.Link K. An indirect haemagglutination test for serum antibodies againstMycoplasma pneumoniae using formalinized, tanned sheep erythrocytes. Acta path. microbiol. scand. 1968;73:459–472. doi: 10.1111/j.1699-0463.1968.tb04615.x. [DOI] [PubMed] [Google Scholar]
  • 22.Lind K. Incidence ofMycoplasma pneumoniae infection in Denmark from 1958 to 1969. Acta path. microbiol. scand. Sect. 1971;B 79:239–247. doi: 10.1111/j.1699-0463.1971.tb02151.x. [DOI] [PubMed] [Google Scholar]
  • 23.Lind, K.: Personal communication.
  • 24.Lind K., Spencer E. S., Andersen H. K. Cold agglutinin production and cytomegalovirus infection. Scand. J. infect. Dis. 1974;6:109–112. doi: 10.3109/inf.1974.6.issue-2.02. [DOI] [PubMed] [Google Scholar]
  • 25.Mårdh P.-A. Human respiratory tract infections with mycoplasmas and theirin vitro susceptibility to tetracyclines and some other antibiotics. Chemotherapy. 1975;21(Suppl. 1):47–57. doi: 10.1159/000221891. [DOI] [PubMed] [Google Scholar]
  • 26.Mårdh P.-A., Skude G., Åkerman M., Ursing B. Mycoplasma pneumoniae infection: A cause of acute pancreatitis and non-specific, reactive hepatitis in man and experimentally infected animals. Paris: INSERM; 1974. pp. 403–410. [Google Scholar]
  • 27.Mårdh P.-A., Taylor-Robinson D. New approaches to the isolation of mycoplasmas. Med. microbiol. Immunol. 1973;158:259–266. doi: 10.1007/BF02121412. [DOI] [PubMed] [Google Scholar]
  • 28.Mårdh P.-A., Ursing B., Lind K. Persistent cerebellar symptoms after infection withMycoplasma pneumoniae. Scand. J. infect. Dis. 1975;7:157–160. doi: 10.3109/inf.1975.7.issue-2.14. [DOI] [PubMed] [Google Scholar]
  • 29.Noah N. D. Mycoplasma pneumoniae infection in the United Kingdom-1967–73. Brit. med. J. 1974;II:544–546. doi: 10.1136/bmj.2.5918.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Shepard M. C., Lunceford C. D., Ford D. K., Purcell R. H., Taylor-Robinson D., Razin S., Black F. T. Ureaplasma urealyticum gen. nov., sp. nov.: proposed nomenclature for the human T (T-strain) mycoplasmas. Int. J. syst. Bact. 1974;24:160–171. [Google Scholar]
  • 31.Smith C. B., Friedewald W. T., Chanock R. M. Shedding ofMycoplasma pneumoniae after tetracycline and erythromycin therapy. New Engl. J. Med. 1967;276:1172–1175. doi: 10.1056/NEJM196705252762103. [DOI] [PubMed] [Google Scholar]
  • 32.Standbridge E., Hayflick L. Growth inhibition test for identification ofMycoplasma species utilizing dried antiserum-impregnated paper discs. J. Bact. 1967;93:1392–1396. doi: 10.1128/jb.93.4.1392-1396.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection are provided here courtesy of Nature Publishing Group

RESOURCES